Israel Stock Market: TA-35, Tech Sector and Dual Listings

Market Overview

Israel's equity market occupies a unique position in global investing: it is a developed-market economy with an outsized concentration in high-technology and life sciences sectors, a history of innovation often described as the "Start-Up Nation" ecosystem, and a distinctive capital markets structure where many of its most valuable companies choose to list on US exchanges rather than, or in addition to, the domestic Tel Aviv Stock Exchange.

The Tel Aviv Stock Exchange (TASE) is Israel's primary equity exchange, regulated by the Israel Securities Authority (ISA). It lists companies across sectors including banking, real estate, technology, defense, pharmaceuticals, and chemicals. However, the Israeli equity ecosystem extends well beyond TASE: dozens of Israeli-founded technology and biotechnology companies are listed on the New York Stock Exchange or Nasdaq, forming a large Israel-linked equity universe that is accessible to US investors through their standard brokerage accounts without any need for international market access.

This dual-listing reality means that the Israeli equity market as seen through TASE is somewhat different from the Israeli equity universe as seen by a US investor who can also access the US-listed Israeli tech cluster. Large Israeli companies in cybersecurity, semiconductors, enterprise software, generic pharmaceuticals (Teva), and specialty chemicals may be more efficiently accessed through their US listings. The TASE is particularly important for exposure to Israeli banking (Hapoalim, Leumi), real estate, and companies that have not pursued US primary or dual listings.

Market Classification

Israel was upgraded from emerging market to developed market status by MSCI in May 2010, effective in the MSCI May 2010 index reconstitution. This reclassification reflected the maturation of Israel's financial markets, the quality of its regulatory and legal infrastructure, the sophistication of its banking and capital markets ecosystem, and the full convertibility of the Israeli shekel (ILS). FTSE Russell completed a similar reclassification of Israel to developed market status in 2008, making MSCI's 2010 move a confirmation of what FTSE had already recognized.

Following MSCI reclassification, Israel moved from the MSCI Emerging Markets Index to the MSCI World Index (developed markets). This had a practical implication for investors: broad EM ETFs such as VWO or EEM no longer provided Israel exposure, while developed-market international ETFs such as VEA or EFA began to include Israel. Investors who had Israel exposure through EM ETFs before 2010 found it shifted to developed-market allocations.

Israel is a constituent of the MSCI World Index, FTSE Developed Markets Index, and the MSCI ACWI. Its weight in developed-market indexes is relatively small given Israel's market capitalization relative to major developed markets, but it provides a unique technology and innovation sector exposure not easily replicated by the European or Japanese developed-market allocations that dominate international equity indexes.

How to Invest in Israel

US investors have multiple routes to Israeli equity exposure, which is more convenient than most international markets because of the extensive dual-listing of Israeli companies on US exchanges.

• EIS (iShares MSCI Israel ETF): The primary US-listed ETF providing focused Israel exposure, tracking the MSCI Israel Capped Investable Market Index. Provides access to both TASE-listed and MSCI-included Israeli equities in one vehicle.
• Direct US-listed Israeli stocks: Many Israeli technology and healthcare companies list directly on Nasdaq or NYSE. Check (cybersecurity software), CyberArk Security, Mobileye (autonomous driving technology), Wix.com, Monday.com, and dozens of Israeli biotechnology and specialty pharma companies trade as standard US equities without requiring international brokerage access.
• Teva Pharmaceutical Industries: One of the world's largest generic drug companies, incorporated in Israel and dual-listed on NYSE (TEVA) and TASE. Accessible directly through US brokerage accounts.
• VEA (Vanguard FTSE Developed Markets ETF) or EFA (iShares MSCI EAFE ETF): Broad developed-market ex-US ETFs that include Israel as a country allocation; not Israel-specific but provide incidental exposure.

Direct TASE investment requires a relationship with an Israeli brokerage or a foreign brokerage offering Israeli market access. Given the breadth of US-listed Israeli equities, direct TASE access is less commonly pursued by US retail investors than for most other developed markets.

Tel Aviv Stock Exchange and TA-35 Index

The Tel Aviv Stock Exchange (TASE) has operated as Israel's primary equity exchange since 1953, originally as an informal securities market before gaining formal exchange status. It is regulated by the Israel Securities Authority (ISA) and operates under Israeli securities law. In 2019, TASE became a publicly traded company itself, with shares listed on its own exchange, marking a significant step in its institutional development.

The TA-35 index covers the 35 largest companies listed on TASE by market capitalization, with constituent eligibility also depending on minimum free-float and liquidity criteria. It is a market-capitalization-weighted, free-float-adjusted index reviewed quarterly. Banking is typically the largest sector in the TA-35, with Bank Hapoalim and Bank Leumi among the top weights. Real estate and insurance are also significant. The TA-125 index covers the 125 largest TASE-listed companies and provides broader Israeli market exposure.

TASE operates a unique dual-listing arrangement with major US exchanges: Israeli companies that meet the listing requirements of Nasdaq or NYSE can apply for simultaneous listing on both TASE and the US exchange under a streamlined regulatory framework. This allows Israeli companies to access both US institutional capital and the domestic Israeli investor base. For some major Israeli technology companies, the US listing is their primary or more liquid market, and the TASE listing is secondary.

Technology and Healthcare Concentration

Israel's equity ecosystem is heavily concentrated in technology and healthcare/life sciences relative to its size. This reflects Israel's position as one of the world's leading innovation economies, with per-capita R&D expenditure consistently among the highest globally, a large and internationally active venture capital and startup ecosystem, and a military technology and intelligence heritage that has spawned globally competitive companies in cybersecurity, semiconductors, and communications.

The technology sector includes companies in cybersecurity (CyberArk, Check Point Software), enterprise software (Nice Systems, Amdocs), semiconductor design (Mobileye, which Intel acquired and later partially re-listed), communications technology, and cloud infrastructure. Many of these companies generate the majority of their revenues outside Israel and are functionally global technology businesses that happen to be founded and headquartered in Israel.

The healthcare and pharmaceuticals sector includes Teva Pharmaceutical Industries (one of the world's largest generic drug manufacturers), specialty pharmaceuticals companies, and a large number of Israeli biotech startups that list on US exchanges for access to capital. Israel's life sciences ecosystem benefits from close collaboration between academic research institutions (Hebrew University, Weizmann Institute, Technion), the military's medical research programs, and the commercial biotech sector.

Dual Listings on NYSE and Nasdaq

The dual-listing structure between TASE and US markets is one of the most distinctive features of Israeli capital markets. Under the Israel Securities Authority's regulations and reciprocal arrangements with the SEC, companies listed on Nasdaq or NYSE that also list on TASE can report primarily under US disclosure standards (SEC filings) rather than filing a separate, full Israeli prospectus. This reduces the regulatory burden of maintaining dual listings and makes it practical for Israeli companies to maintain TASE listings alongside their primary US listings.

For US investors, the practical implication is that many well-known Israeli technology companies (Check Point Software, Nice Systems, Amdocs, Wix.com, Monday.com, Fiverr International) trade with full liquidity on Nasdaq without requiring any international market access. These companies' US shares are functionally identical to domestic US-listed stocks for trading, settlement, and custody purposes.

The dual-listing ecosystem also means that the "Israeli equity market" as tracked by TASE indexes does not fully capture the Israeli innovation economy. Many companies that are Israeli in origin, management, and headquarters trade primarily or exclusively on US exchanges and may not be in TASE's TA-35 or TA-125. Investors seeking the broadest Israeli technology exposure should consider both the TASE-anchored universe tracked by EIS and the US-listed Israeli technology companies accessible directly through US equity markets.

Currency Considerations

Israel uses the Israeli new shekel (ILS, also abbreviated as NIS), which is fully convertible and freely tradeable on global foreign exchange markets. The Bank of Israel (BOI) manages monetary policy and has historically been willing to intervene in currency markets to smooth excessive volatility, though the shekel operates primarily as a market-determined floating exchange rate.

The shekel has historically strengthened over time relative to the US dollar, partly reflecting Israel's strong current account position (Israel exports substantial technology services, receives significant US defense aid, and generates tourism revenue) and partly reflecting productivity convergence as a high-innovation economy. However, the shekel can weaken during periods of geopolitical escalation or global risk-off episodes. Investors in TASE-denominated Israeli equities through ETFs like EIS bear ILS/USD currency translation risk on their returns.

For US investors accessing Israeli companies through their US-listed Nasdaq or NYSE shares, there is no currency translation: these shares trade and settle in USD, and company reporting is in USD for SEC purposes. Currency risk exists at the underlying business level (an Israeli company doing business in ILS has exposure to shekel movements), but the investor's account activity is entirely in dollars.

Geopolitical Risk Premium

Israel's geographic and political environment means that Israeli equities carry a geopolitical risk premium that is higher than most other developed-market investments. Israel has faced ongoing security challenges throughout its history, and periods of escalated conflict (including the October 2023 Hamas attack and subsequent Israeli military operations in Gaza, as well as periodic confrontations with Hezbollah and regional proxy forces) have caused episodic sharp sell-offs in Israeli equities and shekel depreciation.

The Israeli economy and its equity market have historically been resilient: past geopolitical escalations have generally been followed by recovery once immediate security uncertainty reduced. However, the tail risk of broader regional conflict, potential involvement of Iran, or geopolitical spillovers from regional tensions represents a real risk that investors in Israeli equities should explicitly account for in their risk assessment.

The Bank of Israel, Israeli government, and major Israeli banks have well-developed crisis response protocols. Israel's economy has high levels of dollar-denominated reserves (the Bank of Israel maintains substantial foreign currency reserves) and significant US government support through annual military aid, which provides some economic backstop. Nevertheless, geopolitical risk is a genuine and differentiated risk factor compared to other developed markets and should be sized accordingly in portfolio construction.

Tax Considerations for US Investors

Israel's domestic withholding tax rate on dividends paid to non-resident investors is 25%. Under the US-Israel Tax Convention (the Convention Between the Government of the United States of America and the Government of Israel with Respect to Taxes on Income), qualifying US investors can claim a reduced rate of 12.5% on portfolio dividends. This makes the US-Israel treaty one of the more favorable among US tax treaties from a withholding tax perspective for portfolio investors.

US investors holding Israeli equities through US-listed ETFs such as EIS will generally receive dividends after Israeli withholding has been applied at the fund level. The ETF's structure and treaty certification processes determine whether the 12.5% treaty rate or the 25% domestic rate is applied to fund-level dividends. Foreign taxes paid at the fund level may be eligible for a US foreign tax credit on the investor's US return.

US investors who hold Israeli equities through their US Nasdaq or NYSE listings (for dual-listed companies) will generally not face Israeli withholding on dividends paid through the US listing mechanism, as these dividends may be characterized differently from dividends paid by Israeli-resident entities. The exact treatment depends on the company's corporate structure and the nature of the dividend. For dual-listed companies that pay dividends, the tax treatment can differ between the TASE and US share classes, and investors should verify with their brokerage or a tax advisor how dividends are being treated for withholding purposes.

Trading Hours

The Tel Aviv Stock Exchange operates Sunday through Thursday, reflecting Israel's working week, which differs from the Monday through Friday schedule of most global markets. TASE is closed on Fridays and Saturdays (the Jewish Sabbath) and on Israeli public holidays. This makes TASE one of the few major exchanges globally that does not follow the standard Monday through Friday trading schedule.

Regular trading on TASE runs from 9:59 a.m. to 5:15 p.m. Israel Standard Time (IST, UTC+2 in winter; IDT, UTC+3 in summer). Israel observes daylight saving time, typically from the last Friday in March through the last Sunday in October, though the exact dates are set annually by the Israeli government. In UTC terms, TASE trading runs approximately from 7:59 a.m. to 3:15 p.m. UTC in winter and from 6:59 a.m. to 2:15 p.m. UTC in summer.

The Sunday trading day is an important consideration for investors who monitor Israeli equities alongside global markets. Events that occur over the weekend (Saturday and Sunday in global financial markets) are first reflected in TASE trading on Sunday morning Israel time, before European or US markets have opened. This can make TASE a leading indicator for geopolitically sensitive events affecting the Middle East or global risk sentiment over a weekend.